Tag:

DARA BioSciences

Latest Headlines

SPOTLIGHT: Dara licenses Bayer drugs

October 17, 2007

DARA BioSciences in Raleigh, NC has licensed in IP and compounds for type 2 diabetes and dyslipidemia from Bayer HealthCare AG. Bayer gets an undisclosed upfront fee along with a schedule of

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
What's your BIO?June 18-21, 2012 — Boston, MA

MORE EVENTS

Press Releases

Featured Jobs

Research & Development Chemist
C3 Jian - Marina Del Rey, CA
Director, Safety Pharmacology and Toxicology
Tesaro - Waltham, MA
Senior Manager, Global Market Insights Job
Celgene Corporation - Summit, NJ, US
Program Lead - Scientific Information Architecture & Search
Merck - Kenilworth, NJ
Sr. Director/Executive Director of Operations, Inflammation and Immunology CRD Job
Celgene Corporation - Tokyo, Ja, US

DARA BioSciences

Latest Headlines

Latest Headlines

SPOTLIGHT: Dara licenses Bayer drugs

THE LIBRARY: WEBINAR

EVENTS

Press Releases

Featured Jobs

A publication of FierceMarkets

The FierceMarkets Network:

Telecom

Healthcare

Government

Energy

Life Sciences

Enterprise IT

Finance

DARA BioSciences

Latest Headlines

Latest Headlines

SPOTLIGHT: Dara licenses Bayer drugs

Related Tags